2-(Methylsulfanyl)-3-(pyridin-2-yl)-3H,4H-thieno[3,2-d]pyrimidin-4-one

Catalog No. :
ACVBYN801
CAS No. :
338780-21-5
Molecular Formula :
C12H9N3OS2
Molecular Weight :
275.36

IUPAC Name:2-(methylthio)-3-(pyridin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one

2-(Methylsulfanyl)-3-(pyridin-2-yl)-3H,4H-thieno[3,2-d]pyrimidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylsulfanyl)-3-(pyridin-2-yl)-3H,4H-thieno[3,2-d]pyrimidin-4-one
IUPAC Name2-(methylthio)-3-(pyridin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one
MDL No.MFCD00140033
Molecular FormulaC12H9N3OS2
Molecular Weight275.36
SMILESO=C1C2=C(C=CS2)N=C(SC)N1C3=NC=CC=C3
InChI KeyCHRQPZVXAHPVPO-UHFFFAOYSA-N
Synonym2-(METHYLSULFANYL)-3-(2-PYRIDINYL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE;2-(methylsulfanyl)-3-(pyridin-2-yl)-3H,4H-thieno[3,2-d]pyrimidin-4-one;Thieno[3,2-d]pyrimidin-4(3H)-one, 2-(methylthio)-3-(2-pyridinyl)-
CAS No.338780-21-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVBYN801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFHXR638 route compound structure diagram
    ACFHXR638109-04-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVBYN801 route product structure diagram
    ACVBYN801338780-21-5
Inquiry

2. ACVBYN801 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVBYN801 route product structure diagram
    ACVBYN801338780-21-5
Inquiry

Comments (0)